Immunization of BALB/cJ mice with the mutated Ccdc85c 18-mer elicited potent tumor rejection or control in all mice, while the un-mutated peptide failed to elicit protection (Fig. 1b lower panel). Here, CCDC85C is linked to neoplasm.